Clinical Development of Aducanumab, an Anti-Abeta Human Monoclonal Antibody Being Investigated for the Treatment of Early Alzheimerʼs Disease - Budd Haeberlein, S; OʼGorman, J; Chiao, P (The journal of prevention of Alzheimerʼs disease, 2017)
et al.